The RNA-seq analyses revealed that IGFBP2 was significantly downregulated in AEC2 cells from the COVID-ARDS group compared with those from other lung disease groups combined (IPF alone and IPF with COVID history) (Fig. 2A, C). Here, IGFBP2 is linked to lung disorder.